Sonendo Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment
04 Outubro 2023 - 9:00AM
Business Wire
The Partnership Agreements Aim to Increase the
Number of Endodontic Practices Offering the GentleWave System
Sonendo, Inc. (NYSE: SONX), a leading dental technology company
and developer of the GentleWave® System, today announced the
signing of two new strategic partnership agreements with the
country’s leading endodontic dental service organizations (DSOs) to
expand patient access to a best-in-class root canal experience. As
a result of these partnerships, the GentleWave System with
CleanFlow™ Technology, which offers a less invasive and less
painful alternative to traditional root canal therapy, will be
available in more endodontic offices nationwide.
Sonendo previously announced the appointment of a dedicated DSO
and special markets leader to accelerate adoption of the GentleWave
System in the fast-growing DSO segment within the industry. These
two new agreements represent the progress of this initiative and
signal significant opportunity in the space. By leveraging
innovative tools like the GentleWave System, the DSO groups can
streamline workflows and reduce the administrative burden on
doctors, allowing them to spend more time providing high-quality
care to patients, while also differentiating their practices.
With a shared commitment to ensuring exceptional care, Sonendo
and its DSO partners aim to increase the number of endodontic
practices offering the GentleWave System, thereby expanding patient
access to superior root canal treatment.
“DSOs are one of the major driving forces behind the
technological transformation that’s revolutionizing the dental
industry,” said Michael Smith, chief commercial officer at Sonendo.
“With this, we look forward to working with our new DSO specialty
partners to further our mission to save teeth and improve
lives.”
For more information about Sonendo and the GentleWave System,
please visit www.sonendo.com. To find a GentleWave doctor in your
area, please visit www.gentlewave.com.
About Sonendo
Sonendo is a commercial-stage medical technology company focused
on saving teeth from tooth decay, the most prevalent chronic
disease globally. Sonendo developed and manufactured the
GentleWave® System, an innovative technology platform designed to
treat tooth decay by cleaning and disinfecting the microscopic
spaces within teeth without the need to remove tooth structure. The
system utilizes a proprietary mechanism of action, which combines
procedure fluid optimization, broad-spectrum acoustic energy, and
advanced fluid dynamics, to debride and disinfect deep regions of
the complex root canal system in a less invasive procedure that
preserves tooth structure. The clinical benefits of the GentleWave
System when compared to conventional methods of root canal therapy
include improved clinical outcomes, such as superior cleaning that
is independent of root canal complexity and tooth anatomy, high and
rapid rates of healing and minimal to no post-operative pain. In
addition, the GentleWave System can improve the workflow and
economics of dental practices and offers patients an effective,
less invasive, and less painful alternative to traditional root
canal therapy.
Sonendo is also the parent company of TDO® Software, the
developer of widely used endodontic practice management software
solutions, designed to simplify practice workflow. TDO Software
integrates practice management, imaging, referral reporting and
CBCT imaging, and offers built-in communication with the GentleWave
System.
For more information about Sonendo and the GentleWave System,
please visit www.sonendo.com. To find a GentleWave doctor in your
area, please visit www.gentlewave.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231005066070/en/
Macy Hyland Crowe PR sonendo@crowepr.com
Sonendo (NYSE:SONX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Sonendo (NYSE:SONX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024